Literature DB >> 9036958

Dendritic cells that process and present nominal antigens to naive T lymphocytes are derived from CD2+ precursors.

M Takamizawa1, A Rivas, F Fagnoni, C Benike, J Kosek, H Hyakawa, E G Engleman.   

Abstract

Dendritic cells (DC) are potent APC that, in mature form, can be distinguished from other mononuclear cells on the basis of their distinct morphology, absence of lineage markers, and dense expression of MHC and costimulatory molecules. While comparing different DC preparation methods, we observed that DC derived from cultured PBMC that had been depleted of CD2+ cells before culture were functionally distinct from DC derived from PBMC that had not been depleted of CD2+ cells. Thus, both types of DC stimulated allogeneic T cells to proliferate in the MLR, but only DC derived from CD2+ precursors could sensitize naive T cells to soluble Ags such as keyhole limpet hemocyanin and HIV gp160 glycoprotein. Subsequent studies confirmed the existence of CD2+ and CD2- DC precursor populations among HLA-DRbright, lineage-negative PBMC. Immediately after their isolation, these populations were morphologically similar to one another by light and electron microscopy, and neither had substantial Ag-presenting activity. After culture for 24 to 48 h with supernatant from PHA-activated PBMC, both populations developed dendrites, formed clusters with T cells, and stimulated allogeneic T cell responses in the MLR as well as autologous T cell responses to tetanus toxoid, a recall Ag. However, CD2+ DC precursors alone gave rise to APC that presented soluble Ags to naive CD4+ T cells, a property that could be inhibited by Abs to CD4, CD11a, and CD28 on T cells or CD86 on DC. The expression of CD54 and CD86 on CD2+ DC precursors was increased markedly after their culture and differentiation, while the expression of these molecules on CD2- DC precursors was not remarkably changed. These findings reveal the existence of two functionally distinct populations of DC, each derived from a phenotypically distinct precursor present in monocyte-depleted peripheral blood.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9036958

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Isolation of dendritic cells from umbilical cord blood using magnetic activated cell sorting or adherence.

Authors:  Yachun Bie; Qiuxiang Xu; Zhenyu Zhang
Journal:  Oncol Lett       Date:  2015-05-11       Impact factor: 2.967

Review 2.  Dendritic cells: potential role in cancer therapy.

Authors:  E G Engleman
Journal:  Cytotechnology       Date:  1997       Impact factor: 2.058

Review 3.  The role of FcεRI expressed in dendritic cells and monocytes.

Authors:  Jeoung-Sook Shin; Alexandra M Greer
Journal:  Cell Mol Life Sci       Date:  2015-02-26       Impact factor: 9.261

4.  CD2 identifies a monocyte subpopulation with immunoglobulin E-dependent, high-level expression of Fc epsilon RI.

Authors:  Y X Cheng; B Foster; S M Holland; A D Klion; T B Nutman; T B Casale; D D Metcalfe; C Prussin
Journal:  Clin Exp Allergy       Date:  2006-11       Impact factor: 5.018

5.  A human dendritic cell subset receptive to the Venezuelan equine encephalitis virus-derived replicon particle constitutively expresses IL-32.

Authors:  Kevin P Nishimoto; Amanda K Laust; Edward L Nelson
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

6.  Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo.

Authors:  R C Fields; K Shimizu; J J Mulé
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

7.  The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection.

Authors:  D H Dockrell; A D Badley; J S Villacian; C J Heppelmann; A Algeciras; S Ziesmer; H Yagita; D H Lynch; P C Roche; P J Leibson; C V Paya
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.